Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126304311 | 12630431 | 1 | I | 20160729 | 20160808 | 20160808 | EXP | US-BAYER-2016-148671 | BAYER | 0.00 | E | M | Y | 0.00000 | 20160808 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126304311 | 12630431 | 1 | PS | NEXAVAR | SORAFENIB | 1 | UNK | 21923 | FILM-COATED TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126304311 | 12630431 | 1 | Hepatocellular carcinoma |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126304311 | 12630431 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126304311 | 12630431 | Alpha 1 foetoprotein increased | |
126304311 | 12630431 | Asthenia | |
126304311 | 12630431 | Blood alkaline phosphatase increased | |
126304311 | 12630431 | Chest pain | |
126304311 | 12630431 | Fatigue | |
126304311 | 12630431 | Hepatic neoplasm | |
126304311 | 12630431 | Metastases to lung | |
126304311 | 12630431 | Pulmonary mass |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126304311 | 12630431 | 1 | 2016 | 0 |